Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Total Non-Current Liabilities (2016 - 2025)

Ptc Therapeutics has reported Total Non-Current Liabilities over the past 14 years, most recently at $3.1 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $3.1 billion for Q4 2025, up 10.28% from a year ago — trailing twelve months through Dec 2025 was $3.1 billion (up 10.28% YoY), and the annual figure for FY2025 was $3.1 billion, up 10.28%.
  • Total Non-Current Liabilities for Q4 2025 was $3.1 billion at Ptc Therapeutics, up from $2.8 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PTCT hit a ceiling of $3.1 billion in Q4 2025 and a floor of $1.6 billion in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $2.0 billion (2023), compared with a mean of $2.2 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 84.72% in 2021 and later decreased 3.44% in 2025.
  • Ptc Therapeutics' Total Non-Current Liabilities stood at $1.7 billion in 2021, then rose by 11.32% to $1.9 billion in 2022, then skyrocketed by 43.7% to $2.7 billion in 2023, then rose by 3.25% to $2.8 billion in 2024, then rose by 10.28% to $3.1 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $3.1 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.8 billion (Q2 2025) per Business Quant data.